A new defendant has appeared in the case of the former governor of the Penza region

A new defendant has appeared in the case of the former governor of the Penza region

Spread the love

A new defendant has appeared in the case of the former governor of the Penza region

In the case of the former governor of the Penza region, Ivan Belozertsev, accused of corruption, a new defendant has appeared – the general director of a large pharmaceutical company Pharmstandard Grigory Potapov. This is reported by the Baza edition in its Telegram-channel.

According to investigators, Potapov was in a trusting relationship with businessman Boris Shpigel and through him transferred bribes to Belozertsev for patronizing the work of Pharmstandard.

Former Governor Ivan Belozertsev, head of the Biotech group of pharmaceutical companies Boris Shpigel, his wife Yevgenia Shpigel, director of Pharmacy JSC Anton Koloskov, as well as Gennady Markov and Fedor Fedotov, are accused, depending on the role of each of them, under part 5 of article 291 of the Criminal Code of the Russian Federation (“Giving a bribe on an especially large scale”), according to part 6 of Article 290 of the Criminal Code of the Russian Federation (“Taking a bribe on an especially large scale”), according to article 291.1 of the Criminal Code of the Russian Federation (“Mediation in bribery”).

According to the investigation, Belozertsev received a bribe in the form of an expensive watch, a car and 20 million rubles in cash. Spiegel, his wife and Koloskov transferred the illegal remuneration to him through intermediaries, Markov and Fedotov.

Earlier it was reported that the enterprise “Pharmstandard” – Ufa Vitamin Plant “received a comment from the World Health Organization for work on the production of the Russian vaccine” Sputnik V “. The remarks concerned mainly environmental protection and emission monitoring.

Immediately after that, the press secretary of the Russian president, Dmitry Peskov, said that strict control over the production of vaccines was being carried out in Russia, and all the shortcomings identified during the WHO inspection had already been corrected.